Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Management Strategies and Satisfaction Levels in Patients with Sickle Cell Disease: Interim Results from the International Sickle Cell World Assessment Survey (SWAY)

John James, MSc, Biree Andemariam, MD, Baba PD Inusa, MD, Fuad El-Rassi, Beverly Francis-Gibson, Alecia C. Nero, MD, Caterina P. Minniti, MD, Cassandra Trimnell, BA, Miguel R. Abboud, MD, Jean-Benoît Arlet, Raffaella Colombatti, Mariane de Montalembert, MD PhD, Suman Jain, Wasil Jastaniah, Erfan Nur, MD PhD, Laurie DeBonnett, MD, Ifeyinwa (ify) Osunkwo, MD MPH

Blood (2019) 134 (Supplement_1): 1017.

https://doi.org/10.1182/blood-2019-123643

Published: 2019

Journal Articles

The Effect on Blood Use after Adopting Single-Unit Policy and Restrictive Transfusion Trigger in a Hematology Unit: The Ensure Study

Ka Lok Luke Chan, MBBS,MPH,MRCP, Vivien W M Mak, Edmond P H Choi, Ellen L M Yu, Grace W N Lau, Lydia W B Ho, Kevin C H Kwok, Sandy S K Ho, Kate F S Leung, Michael L G Wong, Harold K K Lee

Blood (2018) 132 (Supplement 1): 1259.

https://doi.org/10.1182/blood-2018-99-116630

Published: 2018

Journal Articles

Treatment Patterns and Health/Economic Outcomes in Relapsed/Refractory Follicular Lymphoma: A Real-World Study

Richard van der Jagt, MD FRCPC, Caroline Hamm, MD FRCPC, Isabelle Fleury, MD MSc, FRCP, Véronique Lambert-Obry, M.Sc., Avril Gouault Laliberté, MSc, Alex Castonguay, M.Sc., Dennis Wagner, PhD, Lisa Toltl, PhD, Jean Lachaine, PhD

Blood (2017) 130 (Supplement 1): 5632.

https://doi.org/10.1182/blood.V130.Suppl_1.5632.5632

Published: 2017

Journal Articles

Understanding Treatment and Care Utilization & Perceptions of Females with Hemophilia A or B in the Choice Project

Wendy E. Owens, MA, Jaime Morales Arias, Anissa Cyhaniuk, MA, Elaine Chan, Janet Chupka

Blood (2017) 130 (Supplement 1): 3673.

https://doi.org/10.1182/blood.V130.Suppl_1.3673.3673

Published: 2017

Journal Articles

Treatment Patterns Among Patients with Myelodysplastic Syndromes: Observations of 1 st -Line Therapy, Discontinuation and the Need of Additional Therapies

Sudipto Mukherjee, MD MPH, Christopher R. Cogle, MD, Tanya GK Bentley, PhD, Michael S Broder, MD MSHS, Eunice Chang, PhD, Moira E. Lawrence, PhD, Thomas J. McKearn, MD PhD, Scott Megaffin, Rita Percy, Michael E. Petrone, MD MPH, Gordon H Sun, MD MS

Blood (2014) 124 (21): 2598.

https://doi.org/10.1182/blood.V124.21.2598.2598

Published: 2014

Journal Articles

Impact Of Allogeneic Stem Cell Transplantation On The Health and Economic Burden Of Sickle Cell Disease In Children

Jignesh Dalal, MD, Brian R Lee, MPH, PhD, Matt Hall, PhD, Gerald M Woods, MD, Ram Kalpatthi, MD

Blood (2013) 122 (21): 2924.

https://doi.org/10.1182/blood.V122.21.2924.2924

Published: 2013

Journal Articles

Use Of a Quality Management System and Outcome After Hematopoietic Stem Cell Transplantation

Per T. Ljungman, MD, PhD, Ronald Brand, PhD, Eoin McGrath, van Biezen Anja, Anna Sureda, MD, Helen Baldomero, Christian Chabannon, MD, PhD, Jane F. Apperley, MBChB, FRCP, FRCPath, Alois Gratwohl, MD

Blood (2013) 122 (21): 2945.

https://doi.org/10.1182/blood.V122.21.2945.2945

Published: 2013

Journal Articles

Use of Recombinant Factor VIIa (rFVIIa) for Acute Bleeding Episodes in Acquired Hemophilia: Final Analysis From the Hemostasis and Thrombosis Research Society (HTRS) Registry AH Study

Alice D. Ma, MD, Craig M. Kessler, MD, Hamid A B Al-Mondhiry, MD, Margaret Fisher, PharmD, Robert Z. Gut, MD, PhD, David L. Cooper, MD, MBA

Blood (2012) 120 (21): 4624.

https://doi.org/10.1182/blood.V120.21.4624.4624

Published: 2012

Journal Articles

Cost of Autologous and Allogeneic Stem Cell Transplantations for Hematological Disease: A Dutch Multicenter Daily Practice Study

Hedwig M Blommestein, Silvia GR Verelst, Jan J Cornelissen, MD, PhD, Peter C Huijgens, MD, PhD, Nicole MA Blijlevens, MD, PhD, Carin A Uyl-de Groot, PhD

Blood (2011) 118 (21): 2079.

https://doi.org/10.1182/blood.V118.21.2079.2079

Published: 2011

Journal Articles

Hepatitis B and Hepatitis C Co-Infection in Patients with Hematological Malignancies

Tatyana Ts Garmaeva, Sergey M. Kulikov, Elena A Michailova, Andrei B Sudarikov, Felix P Filatov, Valeryi G Savchenko

Blood (2011) 118 (21): 2090.

https://doi.org/10.1182/blood.V118.21.2090.2090

Published: 2011

Journal Articles

Impact of Dose Reductions and Interruptions Due to Adverse Events (AEs) on Efficacy in Newly Diagnosed Chronic Myeloid Leukemia in ChronicPhase (CML-CP) Patients (pts) Receiving Either Dasatinib (D) or Imatinib(IM): Analysis of the DASISION Trial

Elias Jabbour, Hagop M Kantarjian, Alfonso Quintas-Cardama, Francois Guilhot, MD, Chao Zhu, PhD, Janet Hong, PharmD, Zachary Cain, PharmD, Jorge E. Cortes

Blood (2011) 118 (21): 2768.

https://doi.org/10.1182/blood.V118.21.2768.2768

Published: 2011

Journal Articles

Surgical Experience with Recombinant FVIIa (rFVIIa) in Patients with Hemophilia and Inhibitors to Factors VIII or IX.

Leonard A. Valentino, MD, FAAP, David L. Cooper, MD, MBA

Blood (2009) 114 (22): 1304.

https://doi.org/10.1182/blood.V114.22.1304.1304

Published: 2009

Journal Articles

Plerixafor Plus G-CSF Compared to Chemotherapy Plus G-CSF for Mobilization of Autologous CD34+ Cells Resulted in Similar Cost but More Predictable Days of Apheresis and Less Hospitalization.

Paul Shaughnessy, MD, Miguel Islas-Ohlmayer, MD, Julie Murphy, Maureen Hougham, RN, Jill MacPherson, FNP, Kurt Winkler, PharmD, Matthew Silva, PharmD, Michael Steinberg, PharmD, Jeffrey Matous, MD, Sheryl Selvey, PharmD, Michael Maris, MD, Peter A. McSweeney, MD

Blood (2009) 114 (22): 2277.

https://doi.org/10.1182/blood.V114.22.2277.2277

Published: 2009

Journal Articles

A Canadian Prospective, Observational, Open-Label, Pharmacovigilance Study to Assess the Safety of Humate-P ® Injection Volume Reduced (ivr) in Patients with Von Willebrand Disease.

Alan Tinmouth, MD, FRCPC, Victor S. Blanchette, Ramachandran Devaraj, Bruce Ritchie, David Barnes, Gigi van den Hoef

Blood (2009) 114 (22): 4190.

https://doi.org/10.1182/blood.V114.22.4190.4190

Published: 2009

Journal Articles

Drug Utilization and Cost Considerations of Erythropoiesis-Stimulating Agents in Patients with Myelodysplastic Syndromes.

François Laliberté, MA, Scott R. McKenzie, MD, Brahim K. Bookhart, MBA, MPH, Mei S. Duh, ScD, MPH, Patrick Lefebvre, MA

Blood (2007) 110 (11): 4611.

https://doi.org/10.1182/blood.V110.11.4611.4611

Published: 2007

Journal Articles

A Novel Marker for Blood Platelet Storage Lesion: Newly Synthesized Rap1 in Integrin Signaling.

Peter Schubert, PhD, Jonathan N. Thon, BSc, Geraldine M. Walsh, PhD, Katherine Serrano, PhD, Edwin D. Moore, PhD, Juergen Kast, PhD, Dana V. Devine, PhD

Blood (2007) 110 (11): 4020.

https://doi.org/10.1182/blood.V110.11.4020.4020

Published: 2007

Journal Articles

The Use of Nitrous Oxide To Treat Pain of Lumbar Punctures in Ambulatory Pediatric Leukemia and Lymphoma Patients.

Liesl Hargens, BA, Kathleen Slagerman, RN, Christopher Moertel, MD, Caron Moore, RN, MSW, David Slomiany, MD, Yoav Messinger, MD

Blood (2006) 108 (11): 3306.

https://doi.org/10.1182/blood.V108.11.3306.3306

Published: 2006

Journal Articles

Costs of Imatinib, Costs of Transplants and Gross National Income Per Capita Impact on Transplant Rates for Chronic Myeloid Leukemia in European Countries.

Alois Gratwohl, Helen Baldomero, Alvin Schwendener, Michael Gratwohl, ED, Karl Frauendorfer, Alvaro Urbano-Ispizua

Blood (2006) 108 (11): 2979.

https://doi.org/10.1182/blood.V108.11.2979.2979

Published: 2006

Journal Articles

Comparative Proteome Analysis To Study Novel Markers of the Blood Platelet Lesion.

Peter Schubert, PhD, Jonathan N. Thon, Marie Duguay, Katherine Serrano, PhD, Dana V. Devine, PhD, Juergen Kast, PhD

Blood (2006) 108 (11): 951.

https://doi.org/10.1182/blood.V108.11.951.951

Published: 2006

Journal Articles

Dosing Patterns and Transfusion Use in Cancer Patients Treated with Erythropoietic Agents: Results of an Observational Study of over 8,000 Patients.

Antoine Gosselin, MA, Patrick Lefebvre, MA, Mei S. Duh, MPH, ScD, Scott R. McKenzie, MD, Samir H. Mody, PharmD, MBA, Catherine Tak Piech, MBA

Blood (2005) 106 (11): 3118.

https://doi.org/10.1182/blood.V106.11.3118.3118

Published: 2005

NARROW

Management Strategies and Satisfaction Levels in Patients with Sickle Cell Disease: Interim Results from the International Sickle Cell World Assessment Survey (SWAY)

The Effect on Blood Use after Adopting Single-Unit Policy and Restrictive Transfusion Trigger in a Hematology Unit: The Ensure Study

Treatment Patterns and Health/Economic Outcomes in Relapsed/Refractory Follicular Lymphoma: A Real-World Study

Understanding Treatment and Care Utilization & Perceptions of Females with Hemophilia A or B in the Choice Project

Treatment Patterns Among Patients with Myelodysplastic Syndromes: Observations of 1 st -Line Therapy, Discontinuation and the Need of Additional Therapies

Impact Of Allogeneic Stem Cell Transplantation On The Health and Economic Burden Of Sickle Cell Disease In Children

Use Of a Quality Management System and Outcome After Hematopoietic Stem Cell Transplantation

Use of Recombinant Factor VIIa (rFVIIa) for Acute Bleeding Episodes in Acquired Hemophilia: Final Analysis From the Hemostasis and Thrombosis Research Society (HTRS) Registry AH Study

Cost of Autologous and Allogeneic Stem Cell Transplantations for Hematological Disease: A Dutch Multicenter Daily Practice Study

Hepatitis B and Hepatitis C Co-Infection in Patients with Hematological Malignancies

Impact of Dose Reductions and Interruptions Due to Adverse Events (AEs) on Efficacy in Newly Diagnosed Chronic Myeloid Leukemia in ChronicPhase (CML-CP) Patients (pts) Receiving Either Dasatinib (D) or Imatinib(IM): Analysis of the DASISION Trial

Surgical Experience with Recombinant FVIIa (rFVIIa) in Patients with Hemophilia and Inhibitors to Factors VIII or IX.

Plerixafor Plus G-CSF Compared to Chemotherapy Plus G-CSF for Mobilization of Autologous CD34+ Cells Resulted in Similar Cost but More Predictable Days of Apheresis and Less Hospitalization.

A Canadian Prospective, Observational, Open-Label, Pharmacovigilance Study to Assess the Safety of Humate-P ® Injection Volume Reduced (ivr) in Patients with Von Willebrand Disease.

Drug Utilization and Cost Considerations of Erythropoiesis-Stimulating Agents in Patients with Myelodysplastic Syndromes.

A Novel Marker for Blood Platelet Storage Lesion: Newly Synthesized Rap1 in Integrin Signaling.

The Use of Nitrous Oxide To Treat Pain of Lumbar Punctures in Ambulatory Pediatric Leukemia and Lymphoma Patients.

Costs of Imatinib, Costs of Transplants and Gross National Income Per Capita Impact on Transplant Rates for Chronic Myeloid Leukemia in European Countries.

Comparative Proteome Analysis To Study Novel Markers of the Blood Platelet Lesion.

Dosing Patterns and Transfusion Use in Cancer Patients Treated with Erythropoietic Agents: Results of an Observational Study of over 8,000 Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only